Hoese & CO LLP Pfizer Inc Transaction History

Hoese & CO LLP

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 Apr 08, 2024	SELL	$25.89 - $29.73 $18,381 - $21,108	-710 Reduced 9.57%	6,706 $186,000
Q4 2023 Jan 04, 2024	SELL	$26.13 - $33.94 $10,974 - $14,254	-420 Reduced 5.36%	7,416 $213,000
Q3 2023 Oct 11, 2023	SELL	$32.09 - $37.51 $5,134 - $6,001	-160 Reduced 2.0%	7,836 $259,000
Q2 2023 Jul 12, 2023	SELL	$36.12 - $41.79 $9,752 - $11,283	-270 Reduced 3.27%	7,996 $293,000
Q1 2023 Apr 07, 2023	SELL	$39.39 - $51.28 $37,814 - $49,228	-960 Reduced 10.41%	8,266 $337,000
Q3 2022 Oct 07, 2022	SELL	$43.76 - $53.42 $156,223 - $190,709	-3,570 Reduced 27.9%	9,226 $404,000
Q1 2022 Apr 21, 2022	SELL	$45.75 - $56.69 $52,978 - $65,647	-1,158 Reduced 8.3%	12,796 $662,000
Q3 2021 Oct 20, 2021	BUY	$39.25 - $50.42 $6,201 - $7,966	158 Added 1.15%	13,954 $600,000
Q2 2021 Jul 13, 2021	BUY	$35.91 - $40.68 $79,720 - $90,309	2,220 Added 19.18%	13,796 $540,000
Q1 2021 May 03, 2021	SELL	$33.49 - $37.77 $39,518 - $44,568	-1,180 Reduced 9.25%	11,576 $419,000
Q4 2020 Feb 16, 2021	BUY	$33.47 - $42.56 $426,943 - $542,895	12,756 New	12,756 $470,000

3,260

3.61B

77.2M

122M

Ticker PFE
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 5,612,349,952
Market Cap $148B
Description
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...

Get notified when there are updates to the investment portfolio of Hoese & CO LLP, based on Form 13F filings with the SEC.

Stay updated on Hoese & CO LLP with notifications on news.